Bleeding Disorders - Hematology Advisor

Bleeding Disorders


Researchers assessed 266 pregnant women with and without sickle cell disease in Ghana.

Prevalence of Gastrointestinal Bleeding in Patients With von Willebrand Disease

Risk for gastrointestinal bleeding in adult patients with von Willebrand disease (VWD) may be 2.5 times higher compared with adults without VWD, according to results from a retrospective study published in Thrombosis Research. The study included an identification of risk factors. Prevalence of gastrointestinal bleeding was determined by analyzing National Inpatient Sample (NIS) records of…


Red blood cells macro over red eritrosit background.

Inhibitor Development Is Rare After 75 Days of Exposure to Factor VIII in Severe Hemophilia A

In previously untreated patients with severe hemophilia A, nearly all inhibitory antibodies (inhibitors) against factor VIII develop within 75 days of exposure, according to research published in Blood. Researchers followed 1038 previously untreated pediatric patients with severe hemophilia A who received treatment with factor VIII. Median age of the cohort at first exposure was 1.1…

Esperoct Approval Provides New Treatment Option for Hemophilia A

Novo Nordisk announced that the Food and Drug Administration (FDA) has approved Esperoct (turoctocog alfa pegol, N8-GP) for the treatment of patients with hemophilia A (congenital factor VIII deficiency) for routine prophylaxis to reduce the frequency of bleeding episodes, on-demand treatment and control of bleeding episodes and perioperative management of bleeding.
Next post in Bleeding Disorders